The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| ATON | -81.05% | -99.81% | -71.32% | -100% |
| S&P | +16.89% | +84.17% | +12.98% | +331% |
Portage Biotech, Inc. is a biotechnology company, which enables research and development to produce clinical programs and maximize potential returns. Its portfolio includes subsidiary companies, whose products or technologies have established scientific rationales, including intratumorals, nanoparticles, liposomes, aptamers, cell penetrating peptides, and virus-like particles. It provides funding, strategic business and clinical counsel, and shared services to treat different types of cancers. The company was founded by Gregory H. Bailey in 1973 and is headquartered in Road Town, British Virgin Islands.
No news articles found for AlphaTON Capital.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $0.00K | 0.0% |
| Gross Profit | $0.00K | 100.0% |
| Market Cap | $12.28M | 177.2% |
| Market Cap / Employee | $1.75M | 0.0% |
| Employees | 7 | 0.0% |
| Net Income | -$10,369.00K | -661.3% |
| EBITDA | -$4,503.00K | -180.7% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $183.00K | -89.6% |
| Inventory | 0 | 0.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $0.00K | 0.0% |
| Short Term Debt | $0.00K | -100.0% |
| Q3 2024 | YOY Change | |
|---|---|---|
| Return On Assets | -136.43% | 0.0% |
| Return On Invested Capital | 692.92% | 1101.4% |
| Q3 2024 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$1,565.07K | 0.0% |
| Operating Free Cash Flow | -$1,565.07K | 0.0% |
| Metric | Q1 2024 | Q2 2024 | Q3 2024 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 0.35 | 1.04 | 2.78 | 4.30 | - |
| Price to Tangible Book Value | -4.03 | 1.04 | 2.78 | 4.30 | - |
| Enterprise Value to EBITDA | -1.68 | -0.16 | -2.94 | -2.81 | - |
| Return on Equity | -188.2% | -187.5% | -194.8% | - | |
| Total Debt | $47.00K | $37.00K | $28.00K | $0.00K | - |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
